What are the effects of Diane-35?

When engaging in sexual intercourse and not planning pregnancy, effective contraception is critically important. The most common contraceptive method is the use of condoms; however, contraceptive failure may occasionally occur. In such cases, emergency oral contraception is the best remedial option. When taken correctly, oral contraceptives offer reliable efficacy; therefore, it is essential to avoid missed doses during treatment to ensure optimal effectiveness. So, what is the role of Diane-35? Below, we address this question.

What is the role of Diane-35?

Diane-35 is a short-term oral contraceptive, also known as ethinylestradiol/cyproterone acetate tablets. Its active ingredients are ethinylestradiol and cyproterone acetate. This medication is commonly prescribed for treating polycystic ovary syndrome (PCOS). A standard pack contains 21 tablets, initiated on the first day of the menstrual cycle. After completing the 21-day course, a 7-day drug-free interval follows before starting the next cycle. Some adverse effects associated with Diane-35 include weight gain, headache, abdominal pain, nausea, and vomiting. Rarely, patients may experience hepatic or renal impairment. Diane-35 is contraindicated in women with a history of thrombosis. It should never be self-administered; use must be strictly supervised by a qualified physician.

Knowledge Expansion: Common Types of Oral Contraceptives

1. Long-acting oral contraceptives

Long-acting oral contraceptives are synthetic formulations combining progestin and long-acting estrogen. A single dose provides contraceptive protection for one month, with relatively high efficacy. Common examples include combined norethisterone enanthate (18-methyl), combined quinestrol, and combined chlormadinone acetate (16-methylene). Generally, these agents contain higher drug dosages and thus carry stronger potential side effects.

2. Short-acting oral contraceptives

Short-acting oral contraceptives consist of combined estrogen and progestin and are classified as combined oral contraceptives. They act rapidly and exert multiple contraceptive mechanisms—including suppression of ovulation, inhibition of endometrial gland development, prevention of blastocyst implantation, and alteration of tubal motility. Compared with long-acting formulations, short-acting oral contraceptives generally produce milder side effects and are therefore more widely used.

The above outlines the pharmacological role and clinical considerations for Diane-35. We hope this information proves helpful.